Home > Publications Database > Capacity for brain amyloid PET in Germany: Results from the 1st survey on nuclear brain imaging in Germany. > print

001     281115
005     20250924102922.0
024 7 _ |a 10.1007/s00259-025-07237-8
|2 doi
024 7 _ |a pmid:40140072
|2 pmid
024 7 _ |a pmc:PMC12316748
|2 pmc
024 7 _ |a 1619-7070
|2 ISSN
024 7 _ |a 1619-7089
|2 ISSN
037 _ _ |a DZNE-2025-01076
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Buchert, R.
|0 0000-0002-0945-0724
|b 0
245 _ _ |a Capacity for brain amyloid PET in Germany: Results from the 1st survey on nuclear brain imaging in Germany.
260 _ _ |a Heidelberg [u.a.]
|c 2025
|b Springer-Verl.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1758629067_10849
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
700 1 _ |a Drzezga, A.
|0 P:(DE-2719)2811239
|b 1
|e First author
|u dzne
700 1 _ |a Schreckenberger, M.
|b 2
700 1 _ |a Meyer, P. T.
|b 3
700 1 _ |a Medicine, Working Group Nuclear Brain Imaging of the German Society of Nuclear
|b 4
|e Collaboration Author
773 _ _ |a 10.1007/s00259-025-07237-8
|g Vol. 52, no. 10, p. 3613 - 3617
|0 PERI:(DE-600)2098375-X
|n 10
|p 3613 - 3617
|t European journal of nuclear medicine and molecular imaging
|v 52
|y 2025
|x 1619-7070
856 4 _ |u https://pub.dzne.de/record/281115/files/DZNE-2025-01076%20SUP.docx
856 4 _ |y Restricted
|u https://pub.dzne.de/record/281115/files/DZNE-2025-01076.pdf
856 4 _ |u https://pub.dzne.de/record/281115/files/DZNE-2025-01076.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:pub.dzne.de:281115
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811239
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-05
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-05
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NUCL MED MOL I : 2022
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-05
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-05
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-05
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-05
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J NUCL MED MOL I : 2022
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-05
920 1 _ |0 I:(DE-2719)1011202
|k AG Boecker
|l Positron Emissions Tomography (PET)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1011202
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21